CAR-engineered microglia harness phagocytosis to target brain tumor in organoid models
Cell Reports · 2026-10 · 45 (10) · 118091
DOI: 10.1016/j.celrep.2026.118091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-10. Verfasst von Mu Seog Choe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Interdepartmental Neuroscience Program, Yale Stem Cell Center, Yale Child Study Center, Wu Tsai Institute, Yale School of Med…. Hauptthemen laut MEDLINE: Phagocytosis, Organoids, Microglia, Brain Neoplasms. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Mental Health, Royal Golden Jubilee (RGJ) Ph.D. Programme, National Institutes of Health.
Abstract (Originalsprache)
Glioblastoma (GBM) is among the most aggressive and lethal brain tumors, and standard treatment offers only modest survival benefits. Chimeric antigen receptor (CAR) T cell therapy has transformed the treatment of hematologic cancers, but its efficacy in GBM remains limited. Here we develop a CAR-engineered microglia (CAR-MG) platform and an organoid-based framework to test whether programmable microglial phagocytosis can be directed against GBM. We isolate microglia (MG) from human cortical organoids and engineer them to express a CAR targeting EGFRvIII, a recurrent tumor-specific EGFR deletion variant in GBM. In a 2D co-culture, CAR-MG selectively eliminates GBM cells through phagocytosis. In a 3D GBM-cortical organoid model, CAR-MG infiltrates tumor sites and depletes GBM cells over extended culture. Single-cell RNA sequencing (scRNA-seq) shows elevated phagocytic pathways in CAR-MG and detects internalized tumor-derived transcripts, which resolve phagocytosis-resistance programs. These results support CAR-MG as a myeloid CAR modality for human brain organoid models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Interdepartmental Neuroscience Program, Yale Stem Cell Center, Yale Child Study Center, Wu Tsai Institute, Yale School of Medicine, New Haven, CT 06520, USA.
- Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Neuroelectrophysiology Unit, Chiang Mai University, Chiang Mai 50200, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Ch…
- Center for Precision Cancer Modeling, Yale School of Medicine, New Haven, CT 06520, USA.
- Department of Genetics, Interdepartmental Neuroscience Program, Yale Stem Cell Center, Yale Child Study Center, Wu Tsai Institute, Yale School of Medicine, New Haven, CT 06520, USA. Electronic address: inhyun.park@yale.…
Förderung
- National Institute of Mental Health
- Royal Golden Jubilee (RGJ) Ph.D. Programme
- National Institutes of Health
- Foundation for Angelman Syndrome Therapeutics
- NOMIS Stiftung
- National Research Foundation of Korea
- Swebilius Foundation
- Kavli Foundation
Zitieren
APA
Choe, M. S., Yang, W. S., Cakir, B., Kiral, F. R., Kim, J., Lo, C., Cheng, E., Ongnok, B., Muthusamy, V., Chattipakorn, N., Chattipakorn, S. C., & Park, I. H. (2026). CAR-engineered microglia harness phagocytosis to target brain tumor in organoid models. Cell Reports, 45(10), 118091. https://doi.org/10.1016/j.celrep.2026.118091
Vancouver
Choe MS, Yang WS, Cakir B, Kiral FR, Kim J, Lo C, et al. CAR-engineered microglia harness phagocytosis to target brain tumor in organoid models. Cell Reports. 2026;45(10):118091. doi:10.1016/j.celrep.2026.118091
BibTeX
@article{Choe2026,
author = {Choe, Mu Seog and Yang, Woo Sub and Cakir, Bilal and Kiral, Ferdi Ridvan and Kim, Jonghun and Lo, Cynthia and Cheng, Eena and Ongnok, Benjamin and Muthusamy, Viswanathan and Chattipakorn, Nipon and Chattipakorn, Siriporn C and Park, In-Hyun},
title = {CAR-engineered microglia harness phagocytosis to target brain tumor in organoid models},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {10},
pages = {118091},
doi = {10.1016/j.celrep.2026.118091}
}
EUVIMED